Cargando…
Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
Autores principales: | Choi, Kang-Ho, Kim, Ja-Hae, Lee, Changho, Kim, Jae-Myung, Kang, Kyung-Wook, Kim, Joon-Tae, Choi, Seong-Min, Park, Man-Seok, Cho, Ki-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189857/ https://www.ncbi.nlm.nih.gov/pubmed/34102762 http://dx.doi.org/10.5853/jos.2020.04588 |
Ejemplares similares
-
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021) -
Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021) -
Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed
por: Meng, Ningqin, et al.
Publicado: (2020) -
Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020) -
Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
por: Eun, Mi-Yeon, et al.
Publicado: (2021)